AI Cost Governance in Regulated Industries: Insurance, Banking and Healthcare

Why cost accountability is a runtime problem

Many organizations treat AI spend as a finance exercise. Invoices arrive, usage is allocated to teams, and variances are explained after the fact. That approach can describe how much was consumed, but it cannot show what the AI was permitted to do, which identity consumed it, or what happened during each interaction. For a regulated organization, those are the questions an auditor asks.

In this guide, AI cost governance means three things: attributing usage to an accountable identity, limiting usage through policy, and justifying both with evidence. The limiting and the evidence have to be produced where the usage happens, in the path of each model interaction and tool call. Billing data reconstructed later is a summary. It is not a record of policy decisions.

The NIST AI RMF Govern guidance supports the framing. It points to AI governance policies specific to industry, sector, business purpose and application context, and it recommends explicitly acknowledging that AI systems and their use carry inherent costs and risks. Cost and risk are treated as one governance subject, which is how a regulated organization should treat them.

How the three sectors differ by regulatory driver and evidence expectation

The three sectors share the same underlying question but approach it from different regulatory directions. The comparison below is organized by regulatory driver, data sensitivity and the evidence question each sector must be able to answer. Specific obligations should be mapped with compliance and legal teams against current guidance, since supervisory expectations change.

• Insurance: Driver: state-level oversight, with NAIC and NYDFS as the main reference points. Data: policyholder and claims information, often feeding decisions about individuals. Evidence question: which policy governed this AI use, who owned it, and can that be shown for a given period.
• Banking: Driver: model risk management and supervisory expectations. Data: customer financial information and decision inputs. Evidence question: can the institution show that AI use stayed within approved bounds and that exceptions were escalated.
• Healthcare: Driver: the HIPAA Security and Privacy Rules, with periodic audits of covered entities and business associates required of HHS under HITECH. Data: ePHI, which is the central constraint. Evidence question: what was AI allowed to do with PHI, who or what consumed it, and what happened, proven without exposing PHI.

Healthcare: PHI changes the design

The HIPAA Security Rule establishes national standards to protect electronic protected health information that a covered entity or business associate creates, receives, uses or maintains. Any AI interaction that touches ePHI falls inside that scope. Usage limits, model and tool access, and spend attribution therefore have to be enforced without creating a new exposure.

That has a design consequence for evidence. A usage-attribution record can itself contain or reference ePHI, for example if a prompt or tool response is stored verbatim. Evidence design should be reviewed on the same terms as any other system holding ePHI. The practical goal is a record that identifies the user, agent, model, tool and policy decision, and that either excludes PHI or protects it under the same safeguards.

HIPAA also gives covered entities and business associates discretion in how they meet the 18 Security Rule standards. As CRS describes it, that discretion depends on organization size, complexity and capabilities, technical infrastructure, the costs of security measures, and the probability and criticality of risks to ePHI. For AI usage this means each limit and access rule should carry a documented risk rationale. An auditor is more likely to accept a rate limit or a blocked tool if the reasoning behind it is written down.

Retention needs a deliberate decision. The Privacy Rule requires policies, procedures, notices, complaint dispositions and other required documented actions to be kept until six years after the later of creation or last effective date. That requirement covers Privacy Rule documentation. Whether and how it applies to AI usage evidence is a question for counsel, and retention should be configurable rather than fixed by a tool default.

Finally, HHS is required to audit covered entities and business associates periodically for compliance with the Privacy, Security and Breach Notification Rules. Preparing for that means being able to retrieve current policy documentation and show what AI was permitted to do and what happened.

Where Trussed fits

Trussed enforces policy in the execution path across models, agents, tools, MCP servers, AI sites and coding assistants. It applies allow, redact, block, rate limit and escalate-for-human-approval decisions to individual interactions and tool calls, enforced at runtime, not reviewed after the fact.

That enforcement produces audit-ready evidence, mapped to HIPAA, NAIC, NYDFS, EU AI Act and NIST. Trussed deploys self-managed in the customer cloud, with configurable retention and data residency, and it runs in production with healthcare and pharma organizations. It does not replace the risk rationale, ownership and retention decisions described above. Those remain the regulated enterprise's own.